Home » EV/pembrolizumab yields PFS, OS, ORR benefits regardless of Nectin-4 level

EV/pembrolizumab yields PFS, OS, ORR benefits regardless of Nectin-4 level

by Benjamin P. Saylor & Hannah Clarke | Sep 17, 2024 | Articles | 0 Comments